Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Daiichi Sankyo
AstraZeneca
Julphar
Accenture
Cipla
Medtronic
UBS
Boehringer Ingelheim

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017244

« Back to Dashboard

NDA 017244 describes UTICORT, which is a drug marketed by Parke Davis and is included in four NDAs. Additional details are available on the UTICORT profile page.

The generic ingredient in UTICORT is betamethasone benzoate. There are sixty-six drug master file entries for this compound. Additional details are available on the betamethasone benzoate profile page.
Summary for 017244
Tradename:UTICORT
Applicant:Parke Davis
Ingredient:betamethasone benzoate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:GEL;TOPICALStrength0.025%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Express Scripts
Moodys
Chubb
US Department of Justice
UBS
Medtronic
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot